Perspective highlights AIE nanoparticles' role in tumor detection and targeted therapy, suggesting major advancements for precision oncology.
The future of precision oncology hinges on tools capable of revealing the invisible and treating the intractable. Aggregation‐induced emission (AIE) nanoparticles, uniquely characterized by intensified luminescence upon aggregation, have emerged as intelligent, immune‐compatible platforms precisely suited for this dual mandate. These systems redefine how light interacts with matter and how therapy interfaces with immunity, offering unprecedented opportunities for real‐time tumor detection, targeted therapy, and immunomodulation. This perspective outlines the conceptual foundations, engineering principles, and translational promise of AIE nanoparticles in precision cancer theranostics. By illuminating the unseen and enabling intervention where conventional strategies fail, AIE nanotechnology is poised to fundamentally reshape the landscape of cancer diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Shubhra et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: